Compounds > gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate
Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and cystamine

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with cystamine in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)		Studies
(cystamine)		Trials
(cystamine)		Recent Studies (post-2010) (cystamine)
638312431,2944174

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, Y; Guo, J; Ke, T; Lu, ZR; Parker, DL1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and cystamine

ArticleYear
Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.
    Magnetic resonance imaging, 2006, Volume: 24, Issue:7

    Topics: Absorbable Implants; Animals; Cystamine; Disulfides; Female; Heterocyclic Compounds; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Molecular Structure; Organometallic Compounds; Polyglutamic Acid; Random Allocation; Structure-Activity Relationship

2006